US EditionJournal pulls scientific paper that popularized hydroxychloroquine as COVID-19 treatment
- A COVID study that promoted an unproven treatment has been retracted after a four-year saga.
- The study faced significant scrutiny and criticism from the scientific community throughout its publication.
- Many experts expressed concerns about the implications of promoting unproven treatments during the pandemic.
- The retraction marks the end of an ongoing discussion about the study's impact on COVID treatment.
Insights by Ground AI
Does this summary seem wrong?
38 Articles
38 Articles
All
Left
8
Center
2
Right
2
Controversial study that touted antimalarial drug as COVID-19 treatment withdrawn from scientific journal
Since the study was published in 2020, scientists have pointed to the flawed method and questionable ethics. Three authors are now also taking their hands off the article.
·Netherlands
Read Full Article
Study that promoted Trump's 'miracle drug' as Covid treatment retracted
A controversial study which promoted the use of hydroxychloroquine drug as a treatment for COVID-19 was officially withdrawn from an academic journal. On Tuesday, Elsevier, a Dutch academic publishing company which owns the International Journal of Antimicrobial Agents, issued a retraction of a study which was conducted in March 2020.
·Mumbai, India
Read Full ArticleCoverage Details
Total News Sources38
Leaning Left8Leaning Right2Center2Last UpdatedBias Distribution67% Left
Bias Distribution
- 67% of the sources lean Left
67% Left
L 67%
C 17%
R 17%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
